Legacy Healthcare Announces Positive Top-Line Results from Phase 2/3 Trial of Coacillium cutaneous solution, the first drug for children and adolescents with Moderate and Severe Alopecia Areata
/PRNewswire/ -- Legacy Healthcare, a clinical-stage biopharmaceutical company today announced positive results from the RAAINBOW phase 2/3 randomized...
Source: prnewswire.com